» Articles » PMID: 2586235

Synthesis of Trideuterated O-alkyl Platelet Activating Factor and Lyso Derivatives

Overview
Journal Lipids
Specialty Biochemistry
Date 1989 Sep 1
PMID 2586235
Authors
Affiliations
Soon will be listed here.
Abstract

Racemic heavy isotope analogs of 1-O-alkyl-sn-glycero-3-phosphocholine (lysoPAF) and 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF) were prepared for use as internal standards to facilitate quantitative studies based on mass spectrometry. Starting from pentadecane-1,15-diol and rac-glycerol-1,2-acetonide, a convergent synthesis of 1-O-[16'-2H3]hexadecyl and 1-O-[18'-2H3]octadecyl rac-glycero-3-phosphocholine and their acetyl derivatives is described. Three deuterium atoms were introduced at the terminal position of the 1-O-alkyl group by displacement of the p-toluensulfonyl group from 1-O-alkyl-15'-p-toluensulfonate and 1-O-alkyl-17'-p-toluensulfonate with [2H3]-methylmagnesium iodide. The 1-O-alkyl-17'-p-toluensulfonate was obtained by reaction of the 1-O-alkyl-15'-p-toluensulfonate with allylmagnesium bromide, followed by reductive ozonolysis and treatment with p-toluene-sulfonyl chloride. The hydroxyl group at C-2 was protected by a benzyl group and removed at a late stage in the synthesis. This provided the corresponding lyso-derivatives or allowed preparation of racemic PAF by subsequent acetylation of the free hydroxy group. The phosphocholine moiety was introduced at glycerol C-3 by reaction with bromoethyldichlorophosphate and trimethylamine. The synthetic compounds were analyzed by FAB/MS and GC/NICIMS. They were shown to contain less than 0.6% protium impurity.

References
1.
Tamura M, Harris T, Higashimori K, Sweetman B, Blair I, Inagami T . Lysophosphatidylcholines containing polyunsaturated fatty acids were found as Na+, K+-ATPase inhibitors in acutely volume-expanded hog. Biochemistry. 1987; 26(10):2797-806. DOI: 10.1021/bi00384a022. View

2.
Polonsky J, Tence M, Varenne P, Das B, Lunel J, Benveniste J . Release of 1-O-alkylglyceryl 3-phosphorylcholine, O-deacetyl platelet-activating factor, from leukocytes: chemical ionization mass spectrometry of phospholipids. Proc Natl Acad Sci U S A. 1980; 77(12):7019-23. PMC: 350432. DOI: 10.1073/pnas.77.12.7019. View

3.
Blank M, Snyder F, BYERS L, Brooks B, MUIRHEAD E . Antihypertensive activity of an alkyl ether analog of phosphatidylcholine. Biochem Biophys Res Commun. 1979; 90(4):1194-200. DOI: 10.1016/0006-291x(79)91163-x. View

4.
Godfroid J, Broquet C, Jouquey S, Lebbar M, Heymans F, Redeuilh C . Structure-activity relationship in PAF-acether. 3. Hydrophobic contribution to agonistic activity. J Med Chem. 1987; 30(5):792-7. DOI: 10.1021/jm00388a008. View

5.
Demopoulos C, Pinckard R, HANAHAN D . Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). J Biol Chem. 1979; 254(19):9355-8. View